Ingevity Corporation NGVT R2K

Basic Materials · Specialty Chemicals · United States

https://www.ingevity.com

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Market & Price

Market Cap

$2.36B

Current Price

$67.82

High / Low (52W)

$77.87 / $40.40

Beta

1.24

Valuation

Stock P/E

Industry PE

24.80

Forward P/E

11.78

PEG Ratio

2.41

Book Value

$1.11

Price to Book

60.83

P/S

2.00

EV/EBITDA

9.73

Dividend Yield

Profitability & Returns

ROCE

-4.96%

ROE

-114.08%

ROA

9.03%

Profit Margin

-10.85%

Op Margin

26.74%

EPS (Latest Qtr)

$1.66

EPS (TTM)

$-4.29

Balance Sheet & Liquidity

Debt/Equity

Quick Ratio

0.62

Current Ratio

1.42

Debt

$1.24B

Total Assets

$1.65B

Current Assets

$454.20M

Working Capital

$112.90M

Ownership

Promoter Holding

0.82%

Chg in Prom Hold

FII / Inst Holding

106.37%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$3.51B

Total Revenue (TTM)

$1.18B

EBITDA

$360.60M

Free Cash Flow

$225.80M

Operating Cash Flow

$303.80M

Shares Outstanding

34.77M

Gross Margin

39.57%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

-11.21%

Profit 5Y

-59.66%

Revenue (YoY)

4.10%

Earnings (YoY)

199.00%

PROS

Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Revenue declined at -11.2% CAGR over 5 years.
Earnings shrank at -59.7% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Basic Materials).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	NGVT Ingevity Corporation R2K	67.82	-	$2.36B	-	-4.96%	-114.08%	-11.21%	-59.66%
2	LIN Linde plc NDXSPX	497.69	33.00	$230.11B	1.29%	13.07%	18.23%	0.62%	18.48%
3	NEM Newmont Corporation SPX	109.81	14.24	$117.23B	0.95%	22.51%	25.83%	23.91%	583.84%
4	FCX Freeport-McMoRan Inc. SPX	65.71	34.77	$94.46B	0.91%	12.93%	15.63%	4.39%	-14.02%
5	SHW The Sherwin-Williams Company SPX	303.84	29.16	$74.94B	1.05%	20.04%	60.72%	2.10%	8.34%
6	CRH CRH plc SPX	108.79	20.18	$72.69B	1.43%	11.33%	15.81%	4.60%	-1.15%
7	ECL Ecolab Inc. SPX	256.00	34.59	$72.05B	1.14%	14.89%	22.43%	4.26%	23.88%
8	APD Air Products and Chemicals, Inc. SPX	278.62	29.33	$62.04B	2.60%	-0.62%	12.35%	-1.77%	-39.16%
9	NUE Nucor Corporation SPX	250.00	24.80	$56.94B	0.90%	8.80%	12.29%	-7.84%	-38.80%

Quarterly Results

Figures in USD.

Metric	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	218.50M	260.30M	264.10M	229.50M	235.20M	308.60M	311.20M	278.60M	276.80M	352.80M	359.90M	303.40M	288.20M	270.60M	331.70M	325.60M	320.30M	358.40M	376.80M	382.80M	419.90M	482.00M	392.60M	481.80M	446.00M	340.10M	390.60M	-	-	247.90M	365.10M	333.10M	255.10M	258.00M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	136.00M	227.20M	199.20M	167.30M	141.60M
Gross Profit	76.90M	49.30M	63.00M	74.70M	80.40M	56.30M	70.70M	89.80M	93.20M	75.30M	85.10M	115.50M	118.60M	97.60M	97.10M	134.40M	139.50M	111.00M	114.60M	83.90M	139.60M	127.40M	126.20M	139.80M	141.80M	137.80M	150.60M	176.30M	130.40M	153.00M	129.00M	99.70M	123.20M	-	-	111.90M	137.90M	133.90M	87.80M	116.40M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	48.90M	52.00M	51.10M	49.00M	47.40M
Operating Income	50.70M	-	39.30M	49.20M	49.50M	-	39.90M	57.10M	62.70M	-	67.10M	89.40M	90.70M	-	83.50M	108.30M	114.00M	-	92.20M	67.20M	127.60M	-	105.40M	117.70M	119.50M	119.00M	121.10M	138.20M	103.90M	120.70M	110.40M	76.90M	101.30M	-	-	63.00M	85.90M	82.80M	38.80M	69.00M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83.30M	-97.10M	109.80M	-60.80M	69.90M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20.80M	20.00M	19.60M	16.70M	17.00M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37.60M	-142.70M	62.20M	-105.40M	30.20M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.50M	3.80M	21.40M	-26.60M	6.80M
Net Income	23.80M	8.60M	9.20M	24.10M	-7.20M	9.10M	19.00M	32.10M	33.80M	41.60M	30.80M	46.70M	49.50M	42.10M	22.70M	56.80M	59.90M	44.30M	45.30M	20.20M	69.90M	-	48.70M	44.30M	-4.20M	60.80M	59.80M	75.40M	50.70M	35.50M	25.20M	-56.00M	-283.70M	-	-	20.50M	-146.50M	43.50M	-84.60M	59.80M
Diluted EPS	0.57	0.20	0.22	0.57	-0.17	0.22	0.45	0.76	0.79	0.97	0.72	1.10	1.16	0.99	0.54	1.34	1.41	1.05	1.08	0.49	1.69	1.11	1.20	1.10	-0.11	1.55	1.54	1.98	1.35	0.97	0.69	-1.54	-7.81	-	-	0.56	-4.02	1.18	-2.37	1.66
R&D Expense	-	-	4.60M	4.60M	3.90M	-	5.10M	4.70M	4.80M	-	5.00M	5.30M	5.60M	-	5.10M	5.00M	4.90M	-	6.20M	5.40M	5.20M	-	6.60M	5.90M	6.80M	7.30M	8.20M	7.60M	8.80M	8.00M	7.80M	6.80M	7.30M	6.20M	-	7.00M	7.80M	7.00M	-	6.70M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	908.30M	972.40M	1.13B	1.29B	1.22B	-	1.67B	1.22B	1.20B	1.17B
Cost of Revenue	-	-	-	-	-	-	-	-	1.10B	770.50M	735.30M	706.10M
Gross Profit	318.50M	275.40M	274.40M	329.00M	416.80M	482.00M	465.50M	-	570.10M	445.00M	464.80M	461.50M
Operating Expenses	-	-	-	-	-	-	-	-	229.10M	187.20M	182.30M	199.60M
Operating Income	213.30M	166.30M	163.60M	242.70M	320.50M	396.90M	397.90M	-	341.00M	257.80M	282.50M	261.90M
EBITDA	-	-	-	-	-	-	-	-	440.20M	345.50M	64.40M	41.40M
Interest Expense	-	-	-	-	-	-	-	-	61.80M	92.70M	96.60M	77.10M
Pretax Income	-	-	-	-	-	-	-	-	269.60M	130.00M	-140.50M	-142.10M
Tax Provision	-	-	-	-	-	-	-	-	58.00M	24.20M	-19.10M	8.20M
Net Income	129.00M	79.70M	35.20M	126.50M	169.10M	183.70M	181.40M	-	211.60M	-5.40M	-430.30M	-167.10M
Diluted EPS	3.06	1.89	0.83	2.97	3.97	4.35	4.37	-	5.50	-0.15	-11.85	-4.61
R&D Expense	7.80M	17.40M	17.60M	19.80M	21.50M	19.70M	22.60M	26.30M	30.30M	25.40M	24.50M	28.40M

Compounded Sales Growth

5 Years:	-11.21%
1 Year:	4.10%

Compounded Profit Growth

5 Years:	-59.66%
1 Year:	199.00%

Stock Price Performance

1 Year:	+63.94%
6 Months:	+30.02%
3 Months:	-5.84%
1 Month:	-7.18%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	717.30M	778.70M	832.80M	929.60M	1.32B	2.14B	2.33B	-	2.74B	2.62B	2.02B	1.65B
Current Assets	-	-	-	-	-	-	-	-	-	683.30M	658.60M	493.20M	454.20M
Cash & Equivalents	11.50M	19.90M	32.00M	30.50M	87.90M	77.50M	56.50M	257.70M	-	76.70M	95.90M	68.00M	78.10M
Inventory	-	-	-	-	-	-	-	-	-	335.00M	308.80M	195.90M	186.00M
Receivables	-	-	-	-	-	-	-	-	-	224.80M	182.00M	131.70M	127.20M
Total Liabilities	-	-	261.30M	698.20M	651.70M	976.50M	1.61B	1.69B	-	2.04B	1.99B	1.83B	1.62B
Current Liabilities	-	-	99.80M	136.90M	153.20M	183.30M	215.50M	223.40M	-	303.50M	362.90M	264.10M	341.30M
Long Term Debt	-	-	-	-	-	-	-	-	-	1.47B	1.38B	1.34B	1.16B
Total Debt	-	-	-	-	-	-	-	-	-	1.53B	1.53B	1.45B	1.24B
Total Equity	-	-	513.60M	127.00M	263.90M	338.70M	-	642.10M	-	698.30M	631.40M	195.20M	29.70M
Shares Outstanding	-	-	-	-	-	-	-	-	-	43.23M	43.45M	43.63M	43.89M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	138.50M	72.20M	127.90M	174.30M	252.00M	275.70M	352.40M	-	313.40M	205.10M	128.60M	331.20M
Investing Cash Flow	-96.80M	-89.30M	-126.40M	-58.60M	-414.40M	-658.30M	-110.60M	-	-551.90M	-77.30M	-79.50M	-57.50M
Financing Cash Flow	-31.70M	27.00M	-3.40M	-57.80M	153.70M	369.20M	-50.20M	-	48.10M	-99.90M	-70.20M	-252.20M
Capital Expenditure	-	-	-	-	-93.90M	-114.80M	-82.10M	-	-142.50M	-109.80M	-77.60M	-57.70M
Free Cash Flow	-	-	-	-	158.10M	160.90M	270.30M	-	170.90M	95.30M	51.00M	273.50M
Net Change in Cash	-	-	-	-	-	-	-	-	-190.40M	27.90M	-21.10M	21.50M
Share Buybacks	-	0	0	6.60M	47.40M	6.40M	88.00M	109.40M	145.20M	92.10M	0	56.30M

Ratios (Annual)

Figures in %.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	30.2%	33.8%	36.8%	37.3%	38.3%	-	34.2%	36.6%	38.7%	39.5%
Operating Margin %	-	-	18.0%	25.0%	28.3%	30.7%	32.7%	-	20.4%	21.2%	23.5%	22.4%
Net Margin %	-	-	3.9%	13.0%	14.9%	14.2%	14.9%	-	12.7%	-0.4%	-35.9%	-14.3%
ROE %	-	15.5%	27.7%	47.9%	49.9%	-	28.3%	-	30.3%	-0.9%	-220.4%	-562.6%
ROCE %	-	24.5%	23.5%	31.3%	28.3%	20.6%	18.8%	-	14.0%	11.4%	16.1%	20.0%

Shareholding Pattern

Insiders

0.82%

Institutions

106.37%

Public Float

107.25%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	15.24%	5.30M	$359.29M
2	Vanguard Portfolio Management LLC	6.26%	2.18M	$147.63M
3	Vanguard Capital Management LLC	4.55%	1.58M	$107.28M
4	Wellington Management Group, LLP	4.30%	1.49M	$101.34M
5	State Street Corporation	4.20%	1.46M	$98.97M
6	American Century Companies Inc	4.12%	1.43M	$97.16M
7	Millennium Management Llc	3.32%	1.16M	$78.36M
8	Segall Bryant & Hamill, LLC	3.19%	1.11M	$75.22M
9	Brown Advisory Inc.	2.85%	992.02K	$67.28M
10	Simcoe Capital Management, LLC	2.82%	982.01K	$66.60M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NGVT

No recent headlines available.

NGVT · Basic Materials